-
Mutual fund rating preferred functionality for those doing own investments, says study
Post-COVID a large number of investors have gone digital and doing investments on their own, the survey found.
-
Global cues drag Sensex down by 269 points; Nifty holds 14,800
Sensex slipped 269 points or 0.55% at 48,892 while the broader market index Nifty 50 was at 14,803 down by 47 points or 0.32%.
-
SGX Nifty indicates opening with small losses for Sensex, Nifty
Asian peers trading lower as investors remain cautious over growing inflation worries.
-
Money9 Edit | Inflows in MF space a bright spot in the gloom
The net inflow in the mutual fund space in April for the second-month running offers proof that investors continue to be bullish about the future of the markets.
-
Equity MFs see inflows for second consecutive month in April; here’s what experts say
Mutual funds investor continued with their investment into equity funds, however, the pace has slowed. As per data released by the Association of Mutual Funds in India (AMFI) open-ended equity mutual funds saw a net inflow of Rs 3,437.37 crore against the previous month’s Rs 9,115.12 crore
-
Sensex snaps four-day winning streak skids 340 points; Nifty holds 14,850
At close, Sensex was down 340 points or 0.69% at 49,161, and the Nifty50 sank 91 points or 0.61% to 14,850.
-
Stock market update: Indices turn rangebound
Sensex, declined 412.83 points or 0.83% to 49,090.36. The Nifty 50 index fell 106.35 points or 0.71% at 14,836.10.
-
Money9 Edit | Bots eating up vaccine slots
The need for these bots and their efficiency come into play with citizens finding it virtually impossible to find slots on the official government apps
-
SBI customers can now block, reissue their debit card with just a single call
All you have to do is call on the toll-free IVR system of SBI from your registered phone number. The toll-free IVR number is number - 1800 112 211 and 1800 425 3800
-
Need to ramp up vaccine manufacturing on war footing: Kejriwal tells Centre
The CM said there is an urgent need to ramp up vaccine manufacturing on a war footing due to its shortage across the country.
